Geoffrey F. Joyce

Photo of Geoffrey Joyce

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email media@rand.org.

More Experts »

Codirector, UCLA/RAND Health Services Research Training Program
Off Site Office

Education

Ph.D. in economics, City University of New York; M.P.P., University of Michigan; B.A., Connecticut College

Overview

Biography

Geoffrey F. Joyce is a senior economist at the RAND Corporation, associate professor at the University of Southern California (USC) School of Pharmacy, and senior research faculty member at USC's Leonard D. Schaeffer Center for Health Policy and Economics. His research has been published in leading medical, economic, health policy, and statistics journals and featured in the Wall Street Journal, Washington Post, Los Angeles Times, U.S. News and World Report, and NBC Nightly News, on National Public Radio, and in other media.

Joyce's research focuses on the costs of medical care and the role of insurance. He published four studies in the Journal of the American Medical Association examining the impact of alternative pharmacy benefit designs on prescription drug utilization and spending. He also evaluated the effects of legislative proposals to extend Medicaid price discounts to lower-income residents of all ages. Other studies have examined the lifetime costs of chronic disease among the elderly, the cost-effectiveness of highly active antiretroviral therapy for HIV-infected patients, and differences in medical care utilization and costs under alternative financing arrangements and treatment settings. He is currently examining the impact of high-deductible health plans, health risk assessments, and Medicare Part D.

Joyce is also an adjunct associate professor of health services at UCLA, and a director of the UCLA/RAND Health Services Research Training Program. He received his Ph.D. in economics from City University of New York.

Research Focus

Previous Positions

Senior research analyst in health economics, National Bureau of Economic Research (NBER)

Recent Projects

  • How drug benefits affect (1) medication compliance in private health plans, (2) pharmaceutical use of and costs for military retirees, and (3) the California Special Election that would have extended drug discounts to lower-income residents of all ages
  • The impact of a smoking cessation demonstration for Medicare beneficiaries

Selected Publications

Dana P. Goldman et al., "Prescription Drug Cost Sharing: Associations with Medication and Medical Utilization and Spending and Health," Journal of the American Medical Association, 298(1), 2007

D. P. Goldman et al., "Optimal Drug Benefit Design: The Case of Cholesterol-Lowering Drug Therapy," American Journal of Managed Care, 12(1), 2006

G. F. Joyce et al., "The Lifetime Burden of Chronic Disease Among the Elderly," Health Affairs, 2005

D. P. Goldman et al., "Pharmacy Benefits and the Use of Drugs by the Chronically Ill," Journal of the American Medical Association, 291(19), 2004

G. F. Joyce et al., "Employer Drug Benefit Plans and Spending on Prescription Drugs," Journal of the American Medical Association, 288(14), 2002

Recent Media Appearances

Interviews: Beyond the Beltway; Los Angeles Times; Sage Crossroads; United Press International

Economics

Recent Projects

  • The impact of benefit design on pharmaceutical costs
  • Use of medical care under alternative financing arrangements
  • Cost-effectiveness of smoking cessation for Medicare beneficiaries
  • Changing expenditures for HIV care
  • Impact of alternative Medicare prescription drug benefits

Selected Publications

G. Joyce, S. Morton, and others, "The Effectiveness of Covering Smoking Cessation Services for Medicare Beneficiaries," Health Services Research, 2008

G. Joyce, D. Goldman and others, "Pharmacy Benefit Caps and the Chronically Ill," Health Affairs, 2007

G. Joyce, D. Goldman, and Y. Zheng, "Prescription Drug Cost-Sharing: Associations with Medication and Medical Utilization and Spending, and Health.," JAMA, 2007

G. Joyce, D. Goldman and others, "Benefit Design and Specialty Drug Use," Health Affairs, 2006

G. Joyce, E. Keeler and others, "The Lifetime Burden of Chronic Disease Among the Elderly," Health Affairs, 2005

G. Joyce, D. Goldman and others, "Pharmacy Benefits and Use of Drugs by the Chronically Ill," JAMA, 2004

Commentary

A Simple Rx for Part D — Jan 13, 2006

  • United Press International

Take Two Aspirin and Call Congress — Dec 11, 2002

  • Los Angeles Times

A Third-and Better-Way for Prescription-Drug Coverage — Nov 5, 2000

  • Los Angeles Times

Publications

Coverage and Preventive Screening - 2010

Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill - 2009

Medicare Part D After 2 Years - 2009

Prescription Drug Cost Sharing: A Powerful Policy Lever to Use with Care - 2009

When Drug Cost-Sharing Increases, Patients Newly Diagnosed with a Chronic Illness Delay Starting Medication - 2009

Impact of Specialty Drugs on the Use of Other Medical Services - 2008

Medicare Part D: A Successful Start with Room for Improvement Spending - 2008

Modeling the Health and Medical Care Spending of the Future Elderly - 2008

The Effectiveness of Covering Smoking Cessation Services for Medicare Beneficiaries - 2008

A Look inside the "Doughnut Hole": How Drug-Benefit Limits Affect Retiree Prescription Use - 2007

A Systematic Review of the Adverse Effects of Prescription Drug Cost Sharing - 2007

Bladder and Upper Tract Urothelial Cancer - 2007

Bladder and Upper Tract Urothelial Cancer - 2007

Cryptorchidism and Hypospadias - 2007

Erectile Dysfunction - 2007

Erectile Dysfunction and Peyronie's Disease - 2007

Interstitial Cystitis and Painful Bladder Syndrome - 2007

Kidney Cancer - 2007

Kidney Cancer - 2007

Male Infertility - 2007

Male Infertility - 2007

Male Urethral Stricture Disease - 2007

Male Urethral Stricture Disease - 2007

Mental Health and Substance Abuse Issues Among People with HIV: Lessons from HCSUS - 2007

Methods - 2007

Obesity and Disability: The Shape of Things to Come - 2007

Pediatric Urologic Disorders - 2007

Pharmacy Benefit Caps and the Chronically Ill - 2007

Prescription Drug Cost Sharing: Associations with Medication and Medical Utilization and Spending and Health - 2007

Prostatitis - 2007

Prostatitis - 2007

RAND Review: Vol. 31, No. 3, Fall 2007 - 2007

Testicular Cancer - 2007

Vesicoureteral Reflux and Ureteroceles - 2007

Adverse Selection in Retiree Prescription Drug Plans - 2006

An HIV Collaborative in the VHA: Do Advanced HIT and One-Day Sessions Change the Collaborative Experience? - 2006

Benefit Design and Specialty Drug Use - 2006

Cutting Drug Co-Payments for Sicker Patients on Cholesterol-Lowering Drugs Could Save a Billion Dollars Every Year - 2006

Implementation and Maintenance of Quality Improvement for Treating Depression in Primary Care - 2006

Increasing Costs of Urinary Incontinence Among Female Medicare Beneficiaries - 2006

The Value of Elderly Disease Prevention - 2006

Varying Pharmacy Benefits with Clinical Status: The Case of Cholesterol-Lowering Therapy - 2006

A Socioeconomic Profile of Older Adults with HIV - 2005

Consequences of Health Trends and Medical Innovation for the Future Elderly - 2005

Costs and Effects of Participation in Collaboratives to Improve Chronic Illness Care: Technical Appendix - 2005

Determinants of Dispensing Location in the TRICARE Senior Pharmacy Program - 2005

Economic Costs of Benign Prostatic Hyperplasia in the Private Sector - 2005

Future Health and Medical Care Spending of the Elderly: Implications for Medicare - 2005

How Cost Sharing Affects Use of Drugs by the Chronically Ill - 2005

Mental Health Status and Use of General Medical Services for Person with Human Immunodeficiency Virus - 2005

Moving Towards Better Formulary Management - 2005

Pharmacy Benefits for Military Retirees: Controlling Costs Without Compromising Health - 2005

Pharmacy Use and Costs in Employer-Provided Health Plans: Insights for TRICARE Benefit Design from the Private Sector - 2005

The Lifetime Burden of Chronic Disease Among the Elderly - 2005

Urologic Diseases in America Project: Analytical Methods and Principal Findings - 2005

Disability Forecasts and Future Medicare Costs - 2004

Health Status and Medical Treatment of the Future Elderly: Final Report - 2004

Pharmacy Benefits and the Use of Drugs by the Chronically Ill - 2004

The Changing Face of Pharmacy Benefit Design: A Small Group of Pharmacy Benefit Experts Suggests That Changes Could Be Coming for Tiered Copayment Designs - 2004

Combination Antiretroviral Therapy and Improvements in Mental Health: Results from a Nationally Representative Sample of Persons Undergoing Care for HIV in the United States - 2003

Forecasting the Nursing Home Population - 2003

Insurance Status of HIV-infected Adults in the Post-Haart Era: Evidence from the United States - 2003

Interventions to Promote Smoking Cessation in the Medicare Population - 2003

Cost Sharing Cuts Employers' Drug Spending -- But Employees Don't Get the Savings - 2002

Costs of a Medicare Prescription Drug Benefit: A Comparison of Alternatives - 2002

Employer Drug Benefit Plans and Spending on Prescription Drugs - 2002

The Costs of a Medicare Prescription Drug Benefit - 2002

The Costs of a Medicare Prescription Drug Benefit: A Comparison of Alternatives - 2002

Effect of Insurance on Mortality in an HIV-positive Population in Care - 2001

Expenditures for the Care of HIV-infected Patients in the Era of Highly Active Antiretroviral Therapy - 2001

Medical Care Expenditures Under Gatekeeper and Point-of-Service Arrangements - 2001

The Impact of State Policy on the Cost of HIV Infection - 2001

Expenditures for Physician Services Under Alternative Models of Managed Care - 2000

The Roles of Government and Nonprofit Suppliers in Mixed Industries - 2000

Visits to Primary Care Physicians and to Specialists Under Gatekeeper and Point-of-Service Arrangements - 2000

Variation in Inpatient Resource Use in the Treatment of HIV: Do the Privately Insured Receive More Care? - 1999

Physician Prescribing Behavior and Its Impact on Patient-Level Outcomes -